跳至主要内容
临床试验/EUCTR2014-000936-40-DE
EUCTR2014-000936-40-DE进行中(未招募)1 期

pilot study to investigate the effect of e.-coli-nissle as probiotic adjuvant to antidiabetic standard care in patients with diabetic mellitus type 2 - PUNiDIA

GWT-TUD GmbH0 个研究点开始时间: 2014年5月6日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
GWT-TUD GmbH

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Diabetes mellitus type 2
  • - HbA1c >7% (stable for 6 months)
  • - oral antidiabetic therapie for 6 months with Metformin, Vildagliptin, Gliniden or without Oral antidiabetic medication
  • - age between 45 and 80 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 5
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • -Myocardial infarction or stroke within the last 5 years
  • - insulin therapy
  • -Therapy with arcabose
  • -Acute periphere arterial disease within the last 12 months
  • -Insable metabolic situation
  • -Uncontrolled hypertension
  • -Body-Mass-Index = 35 kg/m²
  • -Daily consumption of probiotic food
  • -Malignant disease within the last 5 years
  • -Status post transplantation
  • -Immunosuppressive therapy within the last 3 months
  • -Therapy with antibiotics
  • -Macroalbuminuria
  • -Severe liver disease

研究者

发起方
GWT-TUD GmbH

相似试验